Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Riedel

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
Plos One|January 22, 2010
17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagyMichael Riedel, Olaf Goldbaum, Lisa Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 27, 2011
Critical trial-related criteria in acute schizophrenia studiesMichael Riedel, Stefan Leucht, Eckart Rüther, et al.
Expert Opinion on Investigational Drugs|July 23, 2004
COX-2 inhibitors as adjunctive therapy in schizophreniaNorbert Müller, Martin Strassnig, Markus J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 3, 2010
Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disordersDamian Läge, Samy Egli, Michael Riedel, et al.
Evidence-Based Mental Health|August 23, 2011
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 yearsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Psychiatry Research|April 24, 2007
T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatmentKatja Maino, Rudolf Gruber, Michael Riedel, et al.
CNS Drugs|March 27, 2009
Management of patients presenting with acute psychotic episodes of schizophreniaPierre Thomas, Köksal Alptekin, Mihai Gheorghe, et al.
Journal of Neuropsychology|May 10, 2017
Response inhibition and interference control: Effects of schizophrenia, genetic risk, and schizotypyUlrich Ettinger, Désirée S Aichert, Nicola Wöstmann, et al.
Psychiatry Research|December 14, 2004
Mycoplasma pneumoniae infection and Tourette's syndromeNorbert Müller, Michael Riedel, Christa Blendinger, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2010
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicityHans-Jürgen Möller, Markus Jäger, Michael Riedel, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
Plos One|January 22, 2010
17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagyMichael Riedel, Olaf Goldbaum, Lisa Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 27, 2011
Critical trial-related criteria in acute schizophrenia studiesMichael Riedel, Stefan Leucht, Eckart Rüther, et al.
Expert Opinion on Investigational Drugs|July 23, 2004
COX-2 inhibitors as adjunctive therapy in schizophreniaNorbert Müller, Martin Strassnig, Markus J Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 3, 2010
Combining the categorical and the dimensional perspective in a diagnostic map of psychotic disordersDamian Läge, Samy Egli, Michael Riedel, et al.
Evidence-Based Mental Health|August 23, 2011
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 yearsFlorian Seemüller, Hans-Jürgen Möller, Michael Obermeier, et al.
Psychiatry Research|April 24, 2007
T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatmentKatja Maino, Rudolf Gruber, Michael Riedel, et al.
CNS Drugs|March 27, 2009
Management of patients presenting with acute psychotic episodes of schizophreniaPierre Thomas, Köksal Alptekin, Mihai Gheorghe, et al.
Journal of Neuropsychology|May 10, 2017
Response inhibition and interference control: Effects of schizophrenia, genetic risk, and schizotypyUlrich Ettinger, Désirée S Aichert, Nicola Wöstmann, et al.
Psychiatry Research|December 14, 2004
Mycoplasma pneumoniae infection and Tourette's syndromeNorbert Müller, Michael Riedel, Christa Blendinger, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 25, 2010
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicityHans-Jürgen Möller, Markus Jäger, Michael Riedel, et al.
Pageof 18